202 related articles for article (PubMed ID: 32396504)
21. Baricitinib as rescue therapy in a patient with COVID-19 with no complete response to sarilumab.
Cingolani A; Tummolo AM; Montemurro G; Gremese E; Larosa L; Cipriani MC; Pasciuto G; Liperoti R; Murri R; Pirronti T; Cauda R; Fantoni M;
Infection; 2020 Oct; 48(5):767-771. PubMed ID: 32642806
[TBL] [Abstract][Full Text] [Related]
22. Kidney Infarction in Patients With COVID-19.
Post A; den Deurwaarder ESG; Bakker SJL; de Haas RJ; van Meurs M; Gansevoort RT; Berger SP
Am J Kidney Dis; 2020 Sep; 76(3):431-435. PubMed ID: 32479921
[TBL] [Abstract][Full Text] [Related]
23. COVID-19 outbreak in Italy: Clinical-radiological presentation and outcome in three oncologic patients.
Colombi D; Bodini FC; Morelli N; Silva M; Milanese G; Cavanna L; Michieletti E
J Infect Chemother; 2021 Jan; 27(1):99-102. PubMed ID: 33023821
[TBL] [Abstract][Full Text] [Related]
24. COVID-19 in Children: Clinical Approach and Management.
Sankar J; Dhochak N; Kabra SK; Lodha R
Indian J Pediatr; 2020 Jun; 87(6):433-442. PubMed ID: 32338347
[TBL] [Abstract][Full Text] [Related]
25. Skin manifestations associated with the new coronavirus SARS-CoV-2 disease.
Redondo-Sendino Á; González Sánchez IC; de Victoria Fernández B
Med Clin (Barc); 2020 Nov; 155(9):414-415. PubMed ID: 32873395
[No Abstract] [Full Text] [Related]
26. Favourable outcome of coronavirus disease 2019 in a patient with anaplastic lymphoma kinase-positive non-small-cell lung cancer receiving alectinib.
Montrone M; Catino A; Palmieri VO; Longo V; Galetta D
Eur J Cancer; 2020 Oct; 138():109-112. PubMed ID: 32871524
[No Abstract] [Full Text] [Related]
27. Inflammation and thrombosis in patients with COVID-19: A prothrombotic and inflammatory disease caused by SARS coronavirus-2.
Pamukçu B
Anatol J Cardiol; 2020 Oct; 24(4):224-234. PubMed ID: 33001051
[TBL] [Abstract][Full Text] [Related]
28. The Good, the Bad, and the Hoax: When Publication Instantaneously Impacts Treatment Strategies for COVID-19.
Danion F; Ruch Y; Fourtage M; Kaeuffer C; Greigert V; Lefebvre N; Muller J; Nai T; Hansmann Y
Antimicrob Agents Chemother; 2020 Jul; 64(8):. PubMed ID: 32513798
[No Abstract] [Full Text] [Related]
29. A systematic review of lopinavir therapy for SARS coronavirus and MERS coronavirus-A possible reference for coronavirus disease-19 treatment option.
Yao TT; Qian JD; Zhu WY; Wang Y; Wang GQ
J Med Virol; 2020 Jun; 92(6):556-563. PubMed ID: 32104907
[TBL] [Abstract][Full Text] [Related]
30. Antiviral mechanisms of candidate chemical medicines and traditional Chinese medicines for SARS-CoV-2 infection.
Li C; Wang L; Ren L
Virus Res; 2020 Sep; 286():198073. PubMed ID: 32592817
[TBL] [Abstract][Full Text] [Related]
31. Lopinavir/ritonavir combination therapy amongst symptomatic coronavirus disease 2019 patients in India: Protocol for restricted public health emergency use.
Bhatnagar T; Murhekar MV; Soneja M; Gupta N; Giri S; Wig N; Gangakhedkar R
Indian J Med Res; 2020 Feb & Mar; 151(2 & 3):184-189. PubMed ID: 32362644
[TBL] [Abstract][Full Text] [Related]
32. Two distinct cases with COVID-19 in kidney transplant recipients.
Kim Y; Kwon O; Paek JH; Park WY; Jin K; Hyun M; Lee JY; Kim HA; Han S
Am J Transplant; 2020 Aug; 20(8):2269-2275. PubMed ID: 32337859
[TBL] [Abstract][Full Text] [Related]
33. Compounds with Therapeutic Potential against Novel Respiratory 2019 Coronavirus.
Martinez MA
Antimicrob Agents Chemother; 2020 Apr; 64(5):. PubMed ID: 32152082
[TBL] [Abstract][Full Text] [Related]
34. Potential strategies for combating COVID-19.
Shamim S; Khan M; Kharaba ZJ; Ijaz M; Murtaza G
Arch Virol; 2020 Nov; 165(11):2419-2438. PubMed ID: 32778950
[TBL] [Abstract][Full Text] [Related]
35. A sporadic COVID-19 pneumonia treated with extracorporeal membrane oxygenation in Tokyo, Japan: A case report.
Nakamura K; Hikone M; Shimizu H; Kuwahara Y; Tanabe M; Kobayashi M; Ishida T; Sugiyama K; Washino T; Sakamoto N; Hamabe Y
J Infect Chemother; 2020 Jul; 26(7):756-761. PubMed ID: 32317225
[TBL] [Abstract][Full Text] [Related]
36. Successful recovery of recurrence of positive SARS-CoV-2 RNA in COVID-19 patient with systemic lupus erythematosus: a case report and review.
He F; Luo Q; Lei M; Fan L; Shao X; Hu K; Qin S; Yu N; Cao J; Yang L
Clin Rheumatol; 2020 Sep; 39(9):2803-2810. PubMed ID: 32725351
[TBL] [Abstract][Full Text] [Related]
37. Broncho-alveolar inflammation in COVID-19 patients: a correlation with clinical outcome.
Pandolfi L; Fossali T; Frangipane V; Bozzini S; Morosini M; D'Amato M; Lettieri S; Urtis M; Di Toro A; Saracino L; Percivalle E; Tomaselli S; Cavagna L; Cova E; Mojoli F; Bergomi P; Ottolina D; Lilleri D; Corsico AG; Arbustini E; Colombo R; Meloni F
BMC Pulm Med; 2020 Nov; 20(1):301. PubMed ID: 33198751
[TBL] [Abstract][Full Text] [Related]
38. Superior Mesenteric Artery Thrombosis and Acute Intestinal Ischemia as a Consequence of COVID-19 Infection.
Cheung S; Quiwa JC; Pillai A; Onwu C; Tharayil ZJ; Gupta R
Am J Case Rep; 2020 Jul; 21():e925753. PubMed ID: 32724028
[TBL] [Abstract][Full Text] [Related]
39. A Randomized Clinical Trial of the Efficacy and Safety of Interferon β-1a in Treatment of Severe COVID-19.
Davoudi-Monfared E; Rahmani H; Khalili H; Hajiabdolbaghi M; Salehi M; Abbasian L; Kazemzadeh H; Yekaninejad MS
Antimicrob Agents Chemother; 2020 Aug; 64(9):. PubMed ID: 32661006
[TBL] [Abstract][Full Text] [Related]
40. Impact of medical care, including use of anti-infective agents, on prognosis of COVID-19 hospitalized patients over time.
Davido B; Boussaid G; Vaugier I; Lansaman T; Bouchand F; Lawrence C; Alvarez JC; Moine P; Perronne V; Barbot F; Saleh-Mghir A; Perronne C; Annane D; De Truchis P;
Int J Antimicrob Agents; 2020 Oct; 56(4):106129. PubMed ID: 32755653
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
